Principles of Clinical Toxicology and Treatment of Acute Poisoning Flashcards
ED50
Effective dose: concentration that produces half of the maximum effect
LD50
Dose that kills half of the subjects exposed
TD50
Dose that produces the half maximum toxicity
Therapeutic index
LD50/ED50
Threshold (non-toxic) dose)
No observed adverse effects below this line
Carcinogenesis
Metabolically activated: Aromatic amines, nitrosamies, PAHs, Aflatoxin
Alkylating agents: cyclophosphamide, melphalan
Teratogenicity Category A
Animal negative/human negative
SAFE
Teratogenicity Category B
Animal negative/human not available OR animal adverse/human negative
Presumed to be safe
Teratogenicity Category C
Animal adverse/human not available OR animal and human not available
Give only if potential benefit justifies risk
Dangerous in 1st trimester
Teratogenicity Category D
Human risk, but benefits to mom may be acceptable in a life threatening/serious disorder
Teratogenicity Category X
Risk of the drug clearly outweighs possible benefit
Contraindicated in women who are or who may become pregnant
Cholinergic or anticholinesterase syndrome- MOA
Organophosphate and carbamate insecticides > inhibition of cholinesterase and accumulation of acetylcholine
Cholinergic or anticholinesterase syndrome symptoms
Muscarinic: sweating, miosis, lacrimation, abdominal cramps, vomiting, diarrhea, bradycardia, hypotension
Nicotinic: Fasiculations, cramps, weakness, paralysis, respiratory compromise
Central: Anxiety, restlessness, coma
Cholinergic or anticholinesterase syndrome treatment
Atropine
Anticholinergic Syndrome MOA
Atropine, scopolamine, tricyclic antidepressants, antihistamines, jimson weed
Too little acetylcholine at the muscarinic receptor site